Guidelines for the identification and management of substance use and substance use disorders in pregnancy
Publicado el 10/10/13
These guidelines have been developed to enable professionals to assist women who are pregnant or have recently had a child, and who use alcohol or drugs or who have a substance use disorder, to achieve healthy outcomes for themselves and their fetus or infant.
Global Smart Update 18: Non-medical use of benzodiazepines: a growing threat to public health?
Publicado el 20/09/18
Non-medical use of prescription benzodiazepines has been a long-established problem that has been associated with a large number of overdose deaths worldwide. Most recently, the concomitant use of benzodiazepines and opioids has been linked to a number of deaths that occurred in the recent opioid crisis, featuring in a rising number of fatalities and adverse events in North America and in Europe. In recent years, several new psychoactive substances (NPS) belonging to the benzodiazepine class have also emerged on the market and are being sold under street names such as “legal benzodiazepines”, “designer benzodiazepines”, and “research chemicals”. The use of such NPS belonging to the benzodiazepine class and the non-medical use of pharmaceutical benzodiazepines pose a great threat to public health.
Hidden Hurt Violence, abuse and disadvantage in the lives of women
Publicado el 15/01/16
The report provides evidence that women who experience the most extensive abuse and violence (both as children and adults) are more likely to face other adverse circumstances in their lives such as poor mental and physical health, disability, and substance misuse, poverty, debt, poor housing, and homelessness. It presents a picture of the scale of violence and abuse these women face, the nature of their experiences, and how their life chances differ from the rest of the population.
Strategy on women’s health and well-being in the WHO European Region
Publicado el 12/09/16
The Strategy on women’s health and well-being in the WHO European Region is based on a review of the evidence, guidance from the governing bodies, feedback from technical experts, results of an online consultation with the Member States, face-to-face consultations in countries and feedback from WHO regions for health and healthy cities networks.